Shares of Sirona Biochem Corp. (CVE:SBM – Get Free Report) rose 5% on Friday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 6,031 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 65,384 shares. The stock had previously closed at C$0.10.
Sirona Biochem Price Performance
The stock has a market cap of C$26.47 million, a P/E ratio of -10.50 and a beta of -0.28. The business has a 50 day simple moving average of C$0.11 and a 200-day simple moving average of C$0.11. The company has a debt-to-equity ratio of 219.21, a quick ratio of 2.41 and a current ratio of 2.05.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Further Reading
- Five stocks we like better than Sirona Biochem
- When to Sell a Stock for Profit or Loss
- MarketBeat Week in Review – 8/28 – 9/1
- Investing in Commodities: What Are They? How to Invest in Them
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- What is a SEC Filing?
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
